Global market to reach US 37 07 B by 2033 at 5 4 CAGR, driven by CAR T, bispecific antibodies, ADCs mAb innovations transforming myeloma treatment https://www.datamintelligence.com/research-report/next-generation-multiple-myeloma-therapies-market